Filing Details

Accession Number:
0001209191-16-116447
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-29 16:14:02
Reporting Period:
2016-04-27
Filing Date:
2016-04-29
Accepted Time:
2016-04-29 16:14:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
913165 Exactech Inc EXAC Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 592603930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206762 J Gary Miller 531 Sw 26Th Place
Gainesville FL 32601
Executive Vice President, R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-04-27 9,851 $24.06 177,609 No 4 S Indirect by Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Partnership
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 30,914 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-Qualified Option (right to buy) $14.27 2011-12-18 2016-12-18 5,000 5,000 Direct
Common Stock Non-Qualified Option (right to buy) $18.95 2014-02-28 2017-02-28 2,800 2,800 Direct
Common Stock Incentive Stock Option (right to buy) $16.33 2017-02-22 2019-02-22 19,800 19,800 Direct
Common Stock Incentive/Non-Qualified Option (right to buy) $18.55 2018-02-25 2020-02-25 16,000 16,000 Direct
Common Stock Non-Qualified Stock Option (right to buy) $20.90 2019-05-09 2021-05-09 12,000 12,000 Direct
Common Stock Non-Qualified Stock Option (right to buy) $23.28 2020-04-29 2022-04-29 9,000 9,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-12-18 5,000 5,000 Direct
2017-02-28 2,800 2,800 Direct
2019-02-22 19,800 19,800 Direct
2020-02-25 16,000 16,000 Direct
2021-05-09 12,000 12,000 Direct
2022-04-29 9,000 9,000 Direct
Footnotes
  1. Such shares were sold pursuant to a Rule 10b5-1 plan to sell a maximum of 50,000 shares of common stock beginning January 4, 2016 and expiring December 30, 2016.
  2. Such options are currently exercisable as regards 15,840 of the covered shares. The remaining options are exercisable, as regards 3,960 of the covered shares, on the fifth anniversary of the date of grant.
  3. Such options are currently exercisable as regards 9,600 of the covered shares. The remaining options are exercisable, as regards 3,200 of the covered shares on the fourth anniversary of the date of grant, and as regards 3,200 of the covered shares, on the fifth anniversary of the date of grant.
  4. Such options are currently exercisable as regards 2,400 of the covered shares. The remaining options are exercisable, as regards 2,400 of the covered shares, on the second anniversary of the date of grant, as regards 2,400 of the covered shares, on the third anniversary of the date of grant, as regards 2,400 of the covered shares on the fourth anniversary of the date of grant, and as regards 2,400 of the covered shares, on the fifth anniversary of the date of grant.
  5. Such options are currently exercisable as regards 1,800 of the covered shares. The remaining options are exercisable, as regards 1,800 of the covered shares, on the second anniversary of the date of grant, as regards 1,800 of the covered shares, on the third anniversary of the date of grant, as regards 1,800 of the covered shares on the fourth anniversary of the date of grant, and as regards 1,800 of the covered shares, on the fifth anniversary of the date of grant.